Acute limb ischemia after femoro-femoral extracorporeal life support implantation: A comparison of surgical, percutaneous, or combined vascular access in 402 patients.


Journal

Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778

Informations de publication

Date de publication:
Nov 2022
Historique:
revised: 25 04 2022
received: 03 02 2022
accepted: 13 06 2022
pubmed: 21 6 2022
medline: 2 11 2022
entrez: 20 6 2022
Statut: ppublish

Résumé

Extracorporeal life support (ECLS) is a salvage treatment for acute circulatory failure. Our high-volume tertiary centre performs more than 100 implants annually and provides ECLS-transports. With this study, we aimed to analyze the incidence and risk factors of limb ischemia depending on the vascular access. Between January 1, 2007, and December 31, 2018, 937 patients received an ECLS. Preoperative, intraoperative, in-hospital and up to 5 years follow-up data were collected. Outcome measures were limb ischemia and survival. In total, 402 femoro-femoral veno-arterial ECLS patients were identified. Mean age was 56 ± 16.7 years, 26.9% were female, 7.9% had a history of peripheral vascular disease. Cannulation was performed percutaneously in 82.1% (n = 330), surgically in 5.7% (n = 23) and combined in 12.2% (n = 49). Mortality was not significantly different between the groups (51.1% percutaneous, 43.5% surgical, 44.9% combined [p = 0.89]). There was no significant difference in limb ischemia either, but a trend toward an increased frequency in the percutaneous group (p = 0.0501). No amputation was necessary. Limb ischemia slightly increased in-hospital mortality (54.6%) but did not affect long-term survival beyond 30 days. Univariate analysis adjusted for cannulation methods revealed younger age and female gender as risk factors of limb ischemia and younger age for limb ischemia after percutaneous cannulation. Our study shows that percutaneous, surgical, and combined vascular access techniques for ECLS implantation are associated with comparable and low incidence of limb ischemia which slightly increases in-hospital mortality. Special precaution has to be taken in young and female patients.

Sections du résumé

BACKGROUND BACKGROUND
Extracorporeal life support (ECLS) is a salvage treatment for acute circulatory failure. Our high-volume tertiary centre performs more than 100 implants annually and provides ECLS-transports. With this study, we aimed to analyze the incidence and risk factors of limb ischemia depending on the vascular access.
METHODS METHODS
Between January 1, 2007, and December 31, 2018, 937 patients received an ECLS. Preoperative, intraoperative, in-hospital and up to 5 years follow-up data were collected. Outcome measures were limb ischemia and survival.
RESULTS RESULTS
In total, 402 femoro-femoral veno-arterial ECLS patients were identified. Mean age was 56 ± 16.7 years, 26.9% were female, 7.9% had a history of peripheral vascular disease. Cannulation was performed percutaneously in 82.1% (n = 330), surgically in 5.7% (n = 23) and combined in 12.2% (n = 49). Mortality was not significantly different between the groups (51.1% percutaneous, 43.5% surgical, 44.9% combined [p = 0.89]). There was no significant difference in limb ischemia either, but a trend toward an increased frequency in the percutaneous group (p = 0.0501). No amputation was necessary. Limb ischemia slightly increased in-hospital mortality (54.6%) but did not affect long-term survival beyond 30 days. Univariate analysis adjusted for cannulation methods revealed younger age and female gender as risk factors of limb ischemia and younger age for limb ischemia after percutaneous cannulation.
CONCLUSIONS CONCLUSIONS
Our study shows that percutaneous, surgical, and combined vascular access techniques for ECLS implantation are associated with comparable and low incidence of limb ischemia which slightly increases in-hospital mortality. Special precaution has to be taken in young and female patients.

Identifiants

pubmed: 35723219
doi: 10.1111/aor.14344
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2284-2292

Informations de copyright

© 2022 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.

Références

Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36:2246-56.
Xie A, Phan K, Tsai YC, Yan TD, Forrest P. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis. J Cardiothorac Vasc Anesth. 2015;29(3):637-64.
Kim H, Lim SH, Hong J, Hong YS, Lee CJ, Jung JH, et al. Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. Resuscitation. 2012;83(8):971-5.
Massetti M, Tasle M, Le Page O, Deredec R, Babatasi G, Buklas D, et al. Back from irreversibility: extracorporeal life support for prolonged cardiac arrest. Ann Thorac Surg. 2005;79(1):178-83.
Chung SY, Sheu JJ, Lin YL, Sun CK, Chang LT, Chen YL, et al. Outcome of patients with profound cardiogenic shock after cardiopulmonary resuscitation and prompt extracorporeal membrane oxygenation support. A single-center observational study. Circ J. 2012;76(6):1385-92.
Avalli L, Maggioni E, Formica F, Redaelli G, Migliari M, Scanziani M, et al. Favourable survival of in-hospital compared to out-of-hospital refractory cardiac arrest treated with extracorporeal membrane oxygenation: an Italian tertiary care Centre experience. Resuscitation. 2012;83(5):579-83.
Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139(2):302-11.
Hsu KH, Chi NH, Yu HY, Wang CH, Huang SC, Wang SS, et al. Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience. Eur J Cardiothorac Surg. 2011;40(3):682-8.
Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg. 2001;71(3 Suppl):S77-81.
Feindt P, Benk C, Boeken U, Bauer A, Mehlhorn U, Gehron J, et al. Use of extracorporeal circulation (ECC) outside the cardiac operating room: indications, requirements and recommendations for routine practice. Thorac Cardiovasc Surg. 2011;59(2):66-8.
Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2014;97:610-6.
Aziz F, Brehm CE, El-Banyosy A, Han DC, Atnip RG, Reed AB. Arterial complications in patients undergoing extracorporeal membrane oxygenation via femoral cannulation. Ann Vasc Surg. 2014;28(1):178-83.
Bisdas T, Beutel G, Warnecke G, Hoeper MM, Kuehn C, Haverich A, et al. Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg. 2011;92(2):626-31.
Tanaka D, Hirose H, Cavarocchi N, Entwistle J. The impact of vascular complications on survival of patients on Venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg. 2016;101(5):1729-34.
Foley PJ, Morris RJ, Woo EY, Acker MA, Wang GJ, Fairman RM, et al. Limb ischemia during femoral cannulation for cardiopulmonary support. J Vasc Surg. 2010;52(4):850-3.
Lamb KM, Hirose H, Cavarocchi NC. Preparation and technical considerations for percutaneous cannulation for veno-arterial extracorporeal membrane oxygenation. J Card Surg. 2013;28(2):190-2.
Wilhelm MJ, Inderbitzin DT, Reser D, Halbe M, Van Tillburg K, Albrecht R, et al. Outcome of inter-hospital transfer of patients on extracorporeal membrane oxygenation in Switzerland. Swiss Med Wkl. 2019;149:w20054.
Juo YY, Skancke M, Sanaiha Y, Mantha A, Jimenez JC, Benharash P. Efficacy of distal perfusion Cannulae in preventing limb ischemia during extracorporeal membrane oxygenation: a systematic review and meta-analysis. Artif Organs. 2017;41(11):E263-73.
Kaufeld T, Beckmann T, Ius F, Koigeldiev N, Sommer W, Mashaqi B, et al. Risk factors for critical limb ischemia in patients undergoing femoral cannulation for venoarterial extracorporeal membrane oxygenation: is distal limb perfusion a mandatory approach? Perfusion. 2019;34(6):453-9.
Slottosch I, Liakopoulos O, Kuhn E, Deppe AC, Scherner M, Madershahian N, et al. Outcomes after peripheral extracorporeal membrane oxygenation therapy for postcardiotomy cardiogenic shock: a single-center experience. J Surg Res. 2013;181(2):e47-55.
Danial P, Hajage D, Nguyen LS, Mastroianni C, Demondion P, Schmidt S, et al. Percutaneous versus surgical femoro-femoral veno-arterial mixed: a propensity score matched study. Intensive Care Med. 2018;44(12):2153-61.
Rupprecht L, Lunz D, Philipp A, Lubnow M, Schmid C. Pitfalls in percutaneous ECMO cannulation. Heart Lung Vessel. 2015;7(4):320-6.
Sin SWC, Ng PY, Ngai WCW, Lai PCK, Mok AYT, Chan RWK. Simulation training for crises during venoarterial extracorporeal membrane oxygenation. J Thorac Dis. 2019;11(5):2144-52.
Ohira O, Kawamura M, Ahern K, Cavarocchi N, Hirose H. Aggressive placement of distal limb perfusion catheter in venoarterial extracorporeal membrane oxygenation. Int J Artif Organs. 2020;43(12):796-802.
Ranney DN, Benrashid E, Meza JM, Keenan JE, Bonadonna D, Mureebe L, et al. Vascular complications and use of a distal perfusion cannula in Femorally cannulated patients on extracorporeal membrane oxygenation. ASAIO J. 2018;64(3):328-33.
Elmously A, Bobka T, Khin S, Afzal A, de Biasi AR, DeBois WJ, et al. Distal perfusion cannulation and limb complications in Venoarterial extracorporeal membrane oxygenation. J Extra Corpor Technol. 2018;50(3):155-60.
Pillai AK, Bhatti Z, Bosserman AJ, Mathew MC, Vaidehi K, Kalva SP. Management of vascular complications of extra-corporeal membrane oxygenation. Cardiovasc Diagn Ther. 2018;8(3):372-7.
Yen CC, Kao CH, Tsai CS, Tsai SH. Identifying the risk factor and prevention of limb ischemia in extracorporeal membrane oxygenation with femoral artery cannulation. Heart Surg Forum. 2018;21(1):E018-22.
Bonicolini E, Martucci G, Simons J, Raffa GM, Spina C, Lo Coco V, et al. Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: a narrative review of incidence, prevention, monitoring, and treatment. Crit Care. 2019;23(1):266.
Yang F, Hou D, Wang J, Cui Y, Wang X, Xing Z, et al. Vascular complications in adult postcardiotomy cardiogenic shock patients receiving venoarterial extracorporeal membrane oxygenation. Ann Intensive Care. 2018;8(1):72.
Lamb KM, DiMuzio PJ, Johnson A, Batista P, Moudgill N, McCullough M, et al. Arterial protocol including prophylactic distal perfusion catheter decreases limb ischemia complications in patients undergoing extracorporeal membrane oxygenation. J Vasc Surg. 2017;65(4):1074-9.

Auteurs

Markus J Wilhelm (MJ)

Clinic for Cardiac Surgery, University Hospital Zürich, Zürich, Switzerland.

Devdas Thomas Inderbitzin (DT)

Clinic for Cardiac Surgery, University Hospital Zürich, Zürich, Switzerland.

Amos Malorgio (A)

Clinic for Cardiac Surgery, University Hospital Zürich, Zürich, Switzerland.

Raed Aser (R)

Clinic for Cardiac Surgery, University Hospital Zürich, Zürich, Switzerland.

Gökhan Gülmez (G)

Clinic for Cardiac Surgery, University Hospital Zürich, Zürich, Switzerland.

Tobias Aigner (T)

Clinic for Cardiac Surgery, University Hospital Zürich, Zürich, Switzerland.

Paul Robert Vogt (PR)

Clinic for Cardiac Surgery, University Hospital Zürich, Zürich, Switzerland.

Diana Reser (D)

Clinic for Cardiac Surgery, University Hospital Zürich, Zürich, Switzerland.
Hirslanden Heart Clinic, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH